EXIA:F:F-iShares DAX ESG UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 7.397

Change

+0.03 (+0.41)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.34 (-0.66%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.03 (+0.05%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.08 (-0.52%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.07%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

-1.20 (-1.25%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 45.80B
0ZC:F Zscaler Inc

+1.75 (+0.85%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.68%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-1.06 (-0.85%)

USD 24.77B

ETFs Containing EXIA:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.95% 91% A- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.95% 90% A- 80% B-
Trailing 12 Months  
Capital Gain 22.75% 91% A- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.75% 89% A- 72% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.93% 70% C- 65% D
Dividend Return 9.93% 67% D+ 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.76% 56% F 88% B+
Risk Adjusted Return 84.41% 82% B 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike